Show simple item record

dc.contributor.authorOwachi, Darius Jason
dc.date.accessioned2018-11-27T13:03:33Z
dc.date.available2018-11-27T13:03:33Z
dc.date.issued2018-10-15
dc.identifier.urihttp://hdl.handle.net/10570/6781
dc.descriptionA dissertation submitted to the Directorate of Research and Graduate Training in partial fulfilment of the requirements for the award of the degree of Master of Medicine in Internal Medicine of Makerere Universityen_US
dc.description.abstractIntroduction: HIV-positive Key populations (KPs) contribute about 50% of the global new HIV infection rates. We sought to compare the rates of virologic suppression, retention in care and factors associated with non-virologic suppression between KPs and general HIV-positive population (GPs) after six months of ART initiation between December 2014 and December 2016. Methods: This was a cross-sectional study conducted at seven public health centers within Kampala from January to March 2018. We reviewed clinical records of HIV-positive KPs (Men who have sex with men and Sex workers) and GPs. Virologic suppression and retention in care were expressed using frequencies (proportions). Factors associated with non-virologic suppression were analyzed using Logistic regression models with level of statistical significance at 0.05. Results: Of the 518 records reviewed, 235 (45%) were KPs. Compared to GPs, KPs had median age of 28 (IQR 25-31) vs. 32 (IQR 27–41) (p<0.01), female proportion 92.8% vs. 64.5% (p <0.01), median baseline CD4 cell count of 447 (IQR 302-672) vs. 313 (IQR 148-463) (p<0.01), and 95% treatment adherence at 71% vs. 92% (P<0.01) respectively. Virologic suppression in KPs vs. GPs was 86.1% vs. 88.6% (p=0.45) and proportion who remained active in care was 82.8% vs. 99% (p<0.01) respectively. KPs who delayed initiation of ART longer by a month were 9.62 times likely to achieve virologic suppression (95%C.I 1.92 – 48.21). Conclusion: KPs achieve comparable virologic suppression rates as GPs but are more likely to drop out of care. KPs need closer follow-up within the first six months of ART to improve retention outcomes.en_US
dc.description.sponsorshipJanneke Cox Infectious Diseases Institute Gilead Foundationen_US
dc.language.isoenen_US
dc.subjectHIVen_US
dc.subjectKEY POPULATIONSen_US
dc.subjectVIROLOGIC SUPPRESSIONen_US
dc.subjectRETENTION IN CAREen_US
dc.subjectGENERAL POPULATIONen_US
dc.titleRetention in care, viral suppression and associated factors in HIV-positive key populations receiving antiretroviral therapy from Kampala Public Health Centersen_US
dc.typeThesisen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record